Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Canopy Growth Corporation - Common Shares
(NQ:
CGC
)
1.230
-0.060 (-4.65%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Canopy Growth Corporation - Common Shares
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
86
87
Next >
EXCLUSIVE: Cannabis Physician Says Surgeon General's Alcohol Cancer Risk Warning Is 'Wake-Up Call'
↗
January 03, 2025
Surgeon general warns about alcohol's cancer risk, suggests updates to health labels. Cannabis stocks largely rise while alcohol stocks drop.
Via
Benzinga
Topics
Cannabis
Recent Scientific Findings Altering Our Knowledge about Marijuana
December 26, 2024
Via
CannabisNewsWire
Topics
Cannabis
Marijuana Users Spend Fewer Days in Hospital for Epilepsy, Study Finds
December 13, 2024
Via
CannabisNewsWire
Topics
Cannabis
EXCLUSIVE: Drug Expert Dr. Carl Hart Slams Cannabis Prohibition Amid Hemp-THC Surge
↗
December 09, 2024
Dr. Carl Hart discusses hemp THC, unregulated markets, and the need for federal cannabis legalization to reduce risks and protect consumers.
Via
Benzinga
Topics
Cannabis
Canopy Growth Wraps Up Acreage Acquisition Expanding US Cannabis Portfolio, What Investors Need To Know
↗
December 09, 2024
Canopy USA, LLC has wrapped up its acquisition of Acreage Holdings, Inc. (CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF), Canopy Growth Corporation's (TSX: WEED) (NASDAQ: CGC) U.S.-domiciled holding...
Via
Benzinga
Topics
Cannabis
Canopy Growth's Earnings Outlook
↗
November 07, 2024
Via
Benzinga
420 with CNW — Federal Court Upholds Ban on Cannabis Advertising in Mississippi
December 05, 2024
Via
CannabisNewsWire
Topics
Cannabis
Law Enforcement
Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand
↗
December 05, 2024
Beyond Canada, this global cannabis company is focused on its international business, particularly in Germany, Australia, and the UK.
Via
Benzinga
Topics
Cannabis
Curaleaf Holdings: Is This Cannabis Company A Buy Or Hold?
↗
December 05, 2024
In this article, we analyze Curaleaf using technical indicators, focusing on key levels and potential mid-term strategies. Let's dive in.
Via
Benzinga
Topics
Cannabis
Decibel Cannabis: One Acquisition Could Be The Key To Unlocking $20M In Cash Flow
↗
December 04, 2024
Decibel, a leading Canadian pre-roll franchise, may trade closer to larger market-cap cannabis stocks, according to analyst Pablo Zuanic.
Via
Benzinga
Topics
Cannabis
Canopy Growth Set To Complete Acreage Acquisition, Leaving Some Shareholders Potentially Open To Losses
↗
December 03, 2024
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) and Acreage Holdings, Inc. (CSE: ACRG.A.U, ACRG.B.U)(OTCQX: ACRHF, ACRDF) announced on Monday that it is anticipated that Canopy USA, LLC will...
Via
Benzinga
Topics
Cannabis
Cannabis Retailer Tokyo Smoke Moves Forward After Major Restructuring
↗
December 02, 2024
Cannabis retailer Tokyo Smoke has finished its restructuring process and is no longer under financial protection, following a court's approval. The Canadian company first announced that it started...
Via
Benzinga
Topics
Cannabis
Flora Growth Taps Europe's CBD Boom With $500K Czech-Slovak Partnership Renewal
↗
November 27, 2024
Via
Benzinga
Canopy USA's Acquisition Of Acreage Could Mean Staggering Losses For Some Shareholders
↗
November 26, 2024
Acreage Holdings, Inc. (CSE:ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF) said it anticipates that Canopy USA, LLC -Canopy Growth Corporation‘s (TSX: WEED) (NASDAQ: CGC) strategy for capturing the U.S....
Via
Benzinga
Topics
Cannabis
Aurora Cannabis Stock Analysis: Key Levels And Trading Opportunities
↗
November 26, 2024
Aurora Cannabis (NASDAQ: ACB) stock finds support at $4.16 amid Fibonacci analysis and bullish divergence. Learn key levels for traders.
Via
Benzinga
Topics
Cannabis
Canopy Growth Names New CEO Who Will Succeed David Klein Amid US Expansion
↗
November 26, 2024
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) announced on Tuesday its board of directors has named Luc Mongeau as the company's next chief executive officer, effective Jan. 6, 2025.Mongeau, a...
Via
Benzinga
Topics
Cannabis
The Canadian Cannabis Report - Monday, Nov 25
↗
November 25, 2024
The past, present and future of the Canadian cannabis sector
Via
Talk Markets
Topics
Cannabis
ETFs
Stocks / Equities
Canopy Growth's German Subsidiary Teams Up With Portugal's Gro-Vida To Expand Medical Cannabis Supply
↗
November 25, 2024
Via
Benzinga
Topics
Cannabis
Maryland Starts Using Dashboard for Tracking Marijuana Use
November 22, 2024
Via
CannabisNewsWire
Topics
Cannabis
What's Happening With Canopy Growth: Is It Time To Buy?
↗
November 21, 2024
Canopy Growth (NASDAQ: CGC) hovers near $3.93. Fibonacci levels suggest key resistance at $6.36 and support at $3.86. Is it worth the risk?
Via
Benzinga
German Cannabis: 20 Tons, 10M Grams - And That's Only 0.3% Of The Market, What's Missing?
↗
November 21, 2024
Medical cannabis users still represent less than 0.3% of the population, indicating significant potential for market expansion.
Via
Benzinga
Topics
Cannabis
Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
↗
November 21, 2024
The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56.
Via
Benzinga
Topics
Cannabis
ETFs
Government
The U.S. Cannabis Strategy No One's Talking About: Inside Canopy's $300M Plan
↗
November 20, 2024
Canopy USA offers investors exposure to the U.S. cannabis market without direct regulatory risk through brands like Wana and Jetty.
Via
Benzinga
Topics
Cannabis
Canopy Growth, Aurora And Another Cannabis Giant Unveil Product Innovations, Here's What's New
↗
November 20, 2024
Cannabis company Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) is launching the award-winning California-grown Claybourne brand in Canada, via an exclusive licensing agreement. Canadian medical...
Via
Benzinga
Topics
Cannabis
Canopy Growth Acquisition Target Acreage Reports 30% YoY Decline In Q3, Record Cannabis Wholesale Revenue In NY
↗
November 15, 2024
Vertically integrated cannabis multi-state operator Acreage Holdings, Inc. (CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF) reported on Thursday its financial results for the third quarter ended Sept....
Via
Benzinga
Topics
Cannabis
New Research Finds Marijuana Use Lowers Opioid and Alcohol Consumption
November 12, 2024
Via
CannabisNewsWire
Topics
Cannabis
The Canadian Cannabis Report- Monday, Nov 11
↗
November 11, 2024
The past, present and fiuture of the Canadian cannabis sector.
Via
Talk Markets
Topics
Cannabis
Canopy Growth (CGC) Q2 2025 Earnings Call Transcript
↗
November 08, 2024
CGC earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Canopy Growth: Q2 Net Revenue Drops 9% YoY, Projects Positive Earnings Ahead
↗
November 08, 2024
Canopy Growth reported 9% a year-over-year decrease in net revenue to CA$63 million ($45.4 million). Adjusted EBITDA loss was CA$6 million, representing a 54% improvement year-over-year, driven...
Via
Benzinga
Aurora vs. Canopy & Tilray: Which NASDAQ-Listed Cannabis Stock Offers The Best Growth Potential?
↗
November 07, 2024
Aurora's international medical cannabis business bolstered its results, with European sales doubling quarter-over-quarter.
Via
Benzinga
Topics
Cannabis
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
86
87
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.